Xilio Therapeutics (XLO) Revenue

219 Followers

Statistics Market Cap Revenue

Xilio Therapeutics Revenue

Xilio Therapeutics had a revenue of 13.69M in the quarter ending Dec 31, 2025, with -28.22%. This bring the company's revenue in the last twelve months to 43.77M, Decreased 37.61%. In the fiscal year ending Dec 31, 2025, Xilio Therapeutics had annual revenue of 43.77M with 589.88% growth.

Revenue (ttm)

43.77M

Revenue Growth

589.88%

P/S Ratio

1.05

Revenue/Employee

$683,844

Employees

Market Cap

$45.80M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	43.77M	37.42M	+589.88%
Dec 31, 2024	6.34M	―	+∞%
Dec 31, 2023	―	―	―
Dec 31, 2022	―	―	―
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―